Hefei Lifeon Pharmaceutical Co., Ltd.
SZSE:003020.SZ
25.2 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 350.796 | 428.847 | 333.618 | 370.753 | 256.711 | 455.974 | 811.817 | 685.153 | 664.961 | 600.609 | 628.617 | 608.357 | 591.089 | 524.715 | 549.094 | 518.091 | 484.161 | 439.526 | 452.514 | 447.89 | 418.3 | 391.921 | 391.921 |
Cost of Revenue
| 119.358 | 123.063 | 103.397 | 111.067 | 93.676 | 206.526 | 515.197 | 456.627 | 415.906 | 364.042 | 382.488 | 371.724 | 355.145 | 305.956 | 333.261 | 345.796 | 307.673 | 287.112 | 320.073 | 307.641 | 280.212 | 272.477 | 272.477 |
Gross Profit
| 231.438 | 305.784 | 230.221 | 259.685 | 163.035 | 249.448 | 296.62 | 228.526 | 249.055 | 236.568 | 246.129 | 236.633 | 235.944 | 218.76 | 215.833 | 172.295 | 176.488 | 152.413 | 132.441 | 140.25 | 138.088 | 119.444 | 119.444 |
Gross Profit Ratio
| 0.66 | 0.713 | 0.69 | 0.7 | 0.635 | 0.547 | 0.365 | 0.334 | 0.375 | 0.394 | 0.392 | 0.389 | 0.399 | 0.417 | 0.393 | 0.333 | 0.365 | 0.347 | 0.293 | 0.313 | 0.33 | 0.305 | 0.305 |
Reseach & Development Expenses
| 17.073 | 11.956 | 23.547 | 23.925 | 17.134 | 30.26 | 12.539 | 23.855 | 21.208 | 17.982 | 13.199 | 22.961 | 13.805 | 16.687 | 12.405 | 9.59 | 14.9 | 14.449 | 4.37 | 20.001 | 6.511 | 5.466 | 5.466 |
General & Administrative Expenses
| 51.144 | -5.284 | 18.046 | -24.655 | 36.764 | -5.366 | 15.164 | 19.342 | 33.9 | -5.987 | 11.666 | -21.17 | 25.85 | -3.185 | 9.529 | 8.251 | -9.507 | -2.732 | 6.174 | -14.648 | 7.766 | 7.759 | 7.759 |
Selling & Marketing Expenses
| 198.439 | 212.132 | 158.409 | 171.755 | 94.887 | 148.444 | 183.366 | 138.642 | 158.218 | 146.991 | 162.524 | 154.162 | 162.014 | 145.962 | 143.103 | 108.86 | 112.953 | 86.093 | 85.904 | 83.29 | 93.966 | 73.101 | 73.101 |
SG&A
| 176.922 | 234.082 | 176.455 | 182.236 | 131.651 | 143.078 | 198.53 | 166.8 | 192.117 | 141.003 | 174.19 | 132.992 | 187.864 | 142.777 | 152.632 | 117.111 | 103.446 | 83.361 | 92.079 | 68.642 | 101.732 | 83.555 | 83.555 |
Other Expenses
| 0.499 | -7.483 | -0.007 | -3.701 | -0.053 | -0.481 | 4.818 | -7.468 | -17.903 | 17.737 | 1.669 | -0.279 | -0.044 | 2.714 | -0.01 | -0.04 | -1.338 | 0.063 | -0.492 | 1.456 | 1.273 | 0 | 0 |
Operating Expenses
| 192.057 | 253.521 | 203.193 | 209.862 | 128.389 | 197.806 | 215.888 | 183.187 | 195.422 | 176.723 | 189.059 | 189.841 | 190.463 | 176.305 | 167.977 | 133.386 | 138.169 | 109.956 | 96.517 | 113.883 | 107 | 89.705 | 89.705 |
Operating Income
| 37.942 | 52.263 | 29.015 | 49.823 | 44.311 | 69.096 | 77.924 | 45.339 | 82.671 | 57.128 | 54.917 | 51.316 | 48.25 | 45.092 | 47.796 | 41.191 | 38.573 | 43.147 | 34.528 | 28.096 | 30.719 | 28.184 | 28.184 |
Operating Income Ratio
| 0.108 | 0.122 | 0.087 | 0.134 | 0.173 | 0.152 | 0.096 | 0.066 | 0.124 | 0.095 | 0.087 | 0.084 | 0.082 | 0.086 | 0.087 | 0.08 | 0.08 | 0.098 | 0.076 | 0.063 | 0.073 | 0.072 | 0.072 |
Total Other Income Expenses Net
| 6.435 | -0.246 | -0.007 | 2.57 | -0.053 | -0.481 | 0.773 | -0.126 | -0.059 | 0.039 | -0.086 | -0.279 | -0.044 | 2.714 | -0.01 | -0.04 | -0.029 | 0.063 | -0.492 | 1.456 | 1.273 | 0.025 | 0.025 |
Income Before Tax
| 44.377 | 59.875 | 29.008 | 65.451 | 44.258 | 68.615 | 78.034 | 45.213 | 82.612 | 57.167 | 54.831 | 51.038 | 48.206 | 47.806 | 47.786 | 41.151 | 38.543 | 43.21 | 34.036 | 29.552 | 31.993 | 30.04 | 30.04 |
Income Before Tax Ratio
| 0.127 | 0.14 | 0.087 | 0.177 | 0.172 | 0.15 | 0.096 | 0.066 | 0.124 | 0.095 | 0.087 | 0.084 | 0.082 | 0.091 | 0.087 | 0.079 | 0.08 | 0.098 | 0.075 | 0.066 | 0.076 | 0.077 | 0.077 |
Income Tax Expense
| 4.713 | 9.398 | 1.553 | 5.457 | 2.557 | 3.627 | 11.893 | 6.514 | 10.233 | 6.124 | 7.704 | 4.153 | 6.448 | 5.913 | 6.095 | 5.697 | 4.927 | 6.2 | 5 | 1.343 | 5.89 | 4.625 | 4.625 |
Net Income
| 41.549 | 47.059 | 30.372 | 55.298 | 40.246 | 64.988 | 66.142 | 38.699 | 72.38 | 51.043 | 47.127 | 46.885 | 41.758 | 41.893 | 41.691 | 35.454 | 33.616 | 37.011 | 29.036 | 28.209 | 26.103 | 25.415 | 25.415 |
Net Income Ratio
| 0.118 | 0.11 | 0.091 | 0.149 | 0.157 | 0.143 | 0.081 | 0.056 | 0.109 | 0.085 | 0.075 | 0.077 | 0.071 | 0.08 | 0.076 | 0.068 | 0.069 | 0.084 | 0.064 | 0.063 | 0.062 | 0.065 | 0.065 |
EPS
| 0.22 | 0.25 | 0.19 | 0.35 | 0.26 | 0.41 | 0.42 | 0.2 | 0.6 | 0.42 | 0.38 | 0.51 | 0.45 | 0.45 | 0.27 | 0.38 | 0.29 | 0.54 | 0.25 | 0.41 | 0.22 | 0.22 | 0.22 |
EPS Diluted
| 0.22 | 0.25 | 0.19 | 0.35 | 0.26 | 0.41 | 0.42 | 0.2 | 0.6 | 0.42 | 0.38 | 0.51 | 0.45 | 0.45 | 0.27 | 0.38 | 0.29 | 0.54 | 0.25 | 0.41 | 0.22 | 0.22 | 0.22 |
EBITDA
| 44.471 | 79.739 | 31.127 | 79.775 | 57.834 | 79.181 | 88.904 | 32.342 | 90.616 | 66.829 | 66.063 | 64.585 | 60.573 | 55.212 | 54.999 | 45.291 | 41.799 | 47.074 | 38.211 | 32.373 | 36.07 | 31.881 | 31.881 |
EBITDA Ratio
| 0.127 | 0.167 | 0.093 | 0.171 | 0.167 | 0.161 | 0.101 | 0.047 | 0.128 | 0.098 | 0.092 | 0.087 | 0.083 | 0.09 | 0.091 | 0.086 | 0.089 | 0.099 | 0.08 | 0.072 | 0.088 | 0.081 | 0.081 |